BetaInsiders sold $80.3M in the past 12 months.0.4% was sold under disclosed trading plans, 99.6% with no plan disclosed. The largest seller, Warren Kanders (CEO and Chairman, Director), sold $73.9M.Share-of-stake figures for this company are being verified and will be added when that check is finished. Why
A share of stake is shown for 0 of the 3 officers and directors who sold. 9 are left out Disclosed company stock is not an insider's whole wealth.i
Left out: Warren Kanders, Nicolas Sokolow, Blaine Browers, Brad Williams, Hamish Norton, William Quigley III, Deborah DeCotis, Gianmaria Delzanno and Mary Kissel (share of stake is being verified).
Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.
Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No officer or director trades were reported for the past 30 days. The most recent before that:
| Who | Shares | Price | % of total stake | Total stake after | Trade date | Filed |
|---|---|---|---|---|---|---|
| Warren Kanders CEO and Chairman, Director | 100,000 | $31.87 | n/a | n/a | Aug 25, 2026 | Aug 26, 2026 |
Yes. Warren Kanders sold 2.04M shares ($73.9M) in the past 12 months, none of it under a trading plan disclosed in the filings.
Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 0.4% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 99.6% had no disclosed plan. A trading plan schedules sales in advance.
No. Officers and directors reported no purchases in the past 12 months.
| Who sold | Amount | % of holdings | Trading plan |
|---|---|---|---|
| Warren Kanders CEO and Chairman, Director | $73.9M 2.04M shares | Not confirmedshare of stake is being verified. Why | No plan disclosed |
| Brad Williams President | $5.5M 148K shares | Not confirmedshare of stake is being verified. Why | 6% under a disclosed plan 94% no plan disclosed |
| Blaine Browers Chief Financial Officer | $895K 20K shares | Not confirmedshare of stake is being verified. Why | No plan disclosed |
Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.
| Insider | Held Oct 13, 2025 | Sold | Held Oct 13, 2026 | Still held | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Warren Kanders!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for Warren Kanders are complete. CEO and Chairman, Director | n/a | −2.04M | n/a | n/a | ||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Warren KandersHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Warren Kanders are complete; balances and unit counts will be added when the check is finished. −12Kgifted (net of own trusts) −801Kwithheld by the company for taxes Stock options (not counted as shares):
Estimate: options held × ($32.28 − strike price), using the most recent insider trade price on Form 4 (Aug 25, 2026), not a market close. | ||||||||||||||||||||||||||||
Nicolas Sokolow!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Nicolas Sokolow are complete. Director | n/a | 0 | n/a | n/a | ||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Nicolas SokolowHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Nicolas Sokolow are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($32.28 − strike price), using the most recent insider trade price on Form 4 (Aug 25, 2026), not a market close. | ||||||||||||||||||||||||||||
Blaine Browers!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Blaine Browers are complete. Chief Financial Officer | n/a | −20K | n/a | n/a | ||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Blaine BrowersHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Blaine Browers are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −4.5Kwithheld by the company for taxes Stock options (not counted as shares):
Estimate: options held × ($32.28 − strike price), using the most recent insider trade price on Form 4 (Aug 25, 2026), not a market close. | ||||||||||||||||||||||||||||
Brad Williams!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for Brad Williams are complete. President | n/a | −148K | n/a | n/a | ||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Brad WilliamsHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Brad Williams are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −3.5Kwithheld by the company for taxes Stock options (not counted as shares):
Estimate: options held × ($32.28 − strike price), using the most recent insider trade price on Form 4 (Aug 25, 2026), not a market close. | ||||||||||||||||||||||||||||
Hamish Norton!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Hamish Norton are complete. Director | n/a | 0 | n/a | n/a | ||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Hamish NortonHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Hamish Norton are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($32.28 − strike price), using the most recent insider trade price on Form 4 (Aug 25, 2026), not a market close. | ||||||||||||||||||||||||||||
William Quigley III!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for William Quigley III are complete. Director | n/a | 0 | n/a | n/a | ||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for William Quigley IIIHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for William Quigley III are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($32.28 − strike price), using the most recent insider trade price on Form 4 (Aug 25, 2026), not a market close. | ||||||||||||||||||||||||||||
Deborah DeCotis!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Deborah DeCotis are complete. Director | n/a | 0 | n/a | n/a | ||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Deborah DeCotisHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Deborah DeCotis are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($32.28 − strike price), using the most recent insider trade price on Form 4 (Aug 25, 2026), not a market close. | ||||||||||||||||||||||||||||
Gianmaria Delzanno!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Gianmaria Delzanno are complete. Director | n/a | 0 | n/a | n/a | ||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Gianmaria DelzannoHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Gianmaria Delzanno are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($32.28 − strike price), using the most recent insider trade price on Form 4 (Aug 25, 2026), not a market close. | ||||||||||||||||||||||||||||
Mary Kissel!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Mary Kissel are complete. Director | n/a | 0 | n/a | n/a | ||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Mary KisselHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Mary Kissel are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($32.28 − strike price), using the most recent insider trade price on Form 4 (Aug 25, 2026), not a market close. | ||||||||||||||||||||||||||||
Holdings and share of stake for Cadre Holdings, Inc. are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.
Officer and director open-market sales: $80.3M across 2,212,752 shares. Plan status and stated purpose are separate questions, and a sale can have both.
The lighter segment is sales with no plan disclosed in the filing ($79.9M), including tax-related sales outside a plan.
Sales with no 10b5-1 plan and no tax reference in the filing. $73.9M of it is Warren Kanders. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Warren Kanders, Nov 17, 2025
808,829 shares ($34.8M) were withheld by the company for taxes, which isn't a market sale.
Gifts the filings describe as charitable. Gifts are not sales and are not included in the sale totals.
| Seller | Shares sold | Proceeds | Under a disclosed plan | Share of total | Sales dates |
|---|---|---|---|---|---|
| Warren Kanders CEO and Chairman, Director | 2.04M | $73.9M | 0% | 92% | Nov 17, 2025 to Aug 25, 2026 |
| Brad Williams President | 148K | $5.5M | 6% | 7% | Oct 14, 2025 to Aug 17, 2026 |
| Blaine Browers Chief Financial Officer | 20K | $895K | 0% | 1% | Dec 12, 2025 to Dec 12, 2025 |
| Month | Sale proceeds | Disclosed plan | To cover taxes | No plan disclosed |
|---|---|---|---|---|
| Oct 2025 | $343K | $343K | $0 | $0 |
| Nov 2025 | $53.6M | $0 | $0 | $53.6M |
| Dec 2025 | $1.9M | $0 | $0 | $1.9M |
| Jan 2026 | $0 | $0 | $0 | $0 |
| Feb 2026 | $0 | $0 | $0 | $0 |
| Mar 2026 | $6.3M | $0 | $0 | $6.3M |
| Apr 2026 | $0 | $0 | $0 | $0 |
| May 2026 | $0 | $0 | $0 | $0 |
| Jun 2026 | $8.6M | $0 | $0 | $8.6M |
| Jul 2026 | $0 | $0 | $0 | $0 |
| Aug 2026 | $9.5M | $0 | $0 | $9.5M |
| Sep 2026 | $0 | $0 | $0 | $0 |
| Oct 2026 | $0 | $0 | $0 | $0 |
In line with the past 3 years. 3 insiders sold; the average is 4 a year.
| 12 months ending | Shares sold | Insiders who sold | Proceeds |
|---|---|---|---|
| Oct 13, 2026 Latest 12 months | 2.21M | 3 | $80.3M |
| Oct 13, 2025 1 year earlier | 1.70M | 4 | $56.5M |
| Oct 13, 2024 2 years earlier | 1.92M | 3 | $66.4M |
| Oct 14, 2023 3 years earlier | 1.92M | 4 | $37.3M |
| Oct 14, 2022 4 years earlier · filings don't cover the whole year | n/a | n/a | n/a |
| Oct 14, 2021 5 years earlier · filings don't cover the whole year | n/a | n/a | n/a |
Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.
Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Cadre Holdings, Inc. are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.
External context: we only cite outside events when a documented connection exists. None is shown for this period.
All 168 Forms 3, 4 and 5 on record for Cadre Holdings, Inc. (SEC CIK 1860543), filed from Nov 3, 2021 to Aug 26, 2026; 31 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 13, 2026. Prices are the ones reported in each filing, often weighted averages.
Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.
Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".
Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.